The Solli team has taken a closer look at PulsePoint’s recently released “Enhancing HCP Marketing Intelligence“, a guide designed for the pharmaceutical sector. It aims to refine HCP marketing through enhanced analytics and deeper insights. Given the digital shift within healthcare, marked by the expansion of telehealth and e-pharmacy, PulsePoint’s publication attempts to address the critical need for advanced HCP marketing approaches.
PulsePoint’s guide outlines the changing dynamics of HCP engagement, transitioning from traditional face-to-face interactions to digital platforms. It discusses the challenges of siloed data within organizations, which can hinder effective marketing strategies. To combat these issues, PulsePoint introduces its HCP365 platform, which integrates National Provider Identifier (NPI) data across marketing channels to enhance ROI and operational efficiency.
PulsePoint champions are using their NPI Identification and Insights solutions like HCP365, making a solid case that these tools could revolutionize marketing efforts. They suggest that by tapping into deep, previously untapped data, companies can keep up and stay ahead in the swiftly evolving digital landscape of healthcare. In their view, adopting such advanced tools isn’t just helpful—it’s crucial for any pharma company wanting to remain competitive and agile.
PulsePoint and other companies are advancing this journey in the global pharmaceutical media space, and we at Solli fully support the commitment to developing thought leadership that makes intelligent HCP marketing accessible and engaging.
There is plenty to be enthused about and explore within this space. For the team at solli we are excited about the following areas for further development:
To get access to PulsePoint’s ‘Enhancing HCP Marketing Intelligence‘ guide click here.